Loading clinical trials...
Loading clinical trials...
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma: A Multicenter, Prospective Blinded Pivotal Study
Conditions
Interventions
Bladder EpiCheck Urine Test
Cystoscopy and pathology
Locations
11
United States
The Urology Center of Colorado
Denver, Colorado, United States
Chesapeake Urology Research Associates
Baltimore, Maryland, United States
Michigan Institute of Urology, P.C.
Troy, Michigan, United States
Metro Urology
Woodbury, Minnesota, United States
Urological Surgeons of Long Island
Garden City, New York, United States
Duke University Health System
Durham, North Carolina, United States
Start Date
September 1, 2016
Primary Completion Date
April 1, 2020
Completion Date
July 1, 2020
Last Updated
May 4, 2021
NCT04235764
NCT07061964
NCT03375307
NCT00026884
NCT07050771
NCT04585750
Lead Sponsor
Nucleix Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions